Watson 369 5 mg (Loxapine Succinate 5 mg)
Pill with imprint Watson 369 5 mg is White, Capsule-shape and has been identified as Loxapine Succinate 5 mg. It is supplied by Watson Laboratories, Inc..
Loxapine is used in the treatment of agitation; agitated state; schizophrenia and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Watson 369 5 mg
Loxapine Succinate
- Imprint
- Watson 369 5 mg
- Strength
- 5 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Miscellaneous antipsychotic agents
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 00591-0369
- Inactive Ingredients
-
lactose anhydrous,
benzyl alcohol,
butylparaben,
edetate calcium disodium,
gelatin,
magnesium stearate,
methylparaben,
polacrilin potassium,
propylparaben,
sodium lauryl sulfate,
sodium propionate,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
More about loxapine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- 12 Reviews
- Drug class: miscellaneous antipsychotic agents
- FDA Alerts (2)
Consumer resources
- Patient Information
- Loxapine inhalation
- Loxapine (Advanced Reading)
- Loxapine Inhalation (Advanced Reading)
- Loxapine Capsules
- Loxapine Inhalation Powder
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.